Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Inoviq Ltd ( (AU:IIQ) ) has shared an announcement.
INOVIQ Ltd announced an upcoming online Investor Briefing scheduled for July 14, 2025, to discuss their EXO-OC ovarian cancer test and CAR-exosome therapy. The briefing will cover recent results in early detection of ovarian cancer and updates on CAR-exosome therapy in breast and lung cancers, highlighting the company’s advancements in cancer diagnostics and therapeutics.
More about Inoviq Ltd
INOVIQ Ltd is a leader in exosome technology, focusing on next-generation diagnostics and therapeutics to transform cancer care and improve patient outcomes. The company’s product portfolio includes commercial-stage exosome isolation products, clinical-stage diagnostics for ovarian and breast cancers, and a preclinical-stage CAR-exosome therapeutic program targeting solid tumors.
Average Trading Volume: 251,256
Technical Sentiment Signal: Sell
Current Market Cap: A$40.75M
Learn more about IIQ stock on TipRanks’ Stock Analysis page.